| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |